Induction and expression of cyclin D3 in human pancreatic cancer

@article{Ebert2001InductionAE,
  title={Induction and expression of cyclin D3 in human pancreatic cancer},
  author={Matthias P. A. Ebert and Sara Hernberg and Guo Fei and Armin A. Sokolowski and H. U. Schulz and Hans Lippert and Peter Malfertheiner},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2001},
  volume={127},
  pages={449-454}
}
Purpose: Cyclins play a key role in the control and regulation of the cell cycle. The role of cyclins in the pathogenesis of pancreatic cancer is largely unknown. Methods: Using Northern blot analysis, polymerase chain reaction (PCR) and immunohistochemistry, we examined the expression of cyclins D1, D2, and D3 in human pancreatic cancer and studied the induction of these cyclins by growth factors in pancreatic cancer cell lines. Results: We now report that cyclin D1 and D3 mRNAs are expressed… 
Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas
TLDR
Examination of D-type cyclin protein overeexpression in relation to the TNM stage of the tumours revealed that overexpression of cyclins D1 and/or D2, but not cyclin D3, is linked to colon carcinogenesis and that overexposure of cyclinD2 may be related to a higher TNMStage of the cancer.
Overexpression of G1-S Cyclins and Cyclin-Dependent Kinases during Multistage Human Pancreatic Duct Cell Carcinogenesis
TLDR
This study investigated the molecular basis for the neoplastic duct cells in this pancreatic intraepithelial neoplasia–carcinoma sequence to acquire progressive enhancement of their proliferative potential and suggest a p16-independent role for cyclin D3 in deregulating the G1-S cell cycle checkpoints during early stages of pancreatic duct cell carcinogenesis.
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
TLDR
The results suggest that CCND3 is the primary driver of the cell cycle, in cooperation with CCND1 that integrates extracellular mitogenic signaling and evidence that CC ND1 plays a role in tumor cell migration is presented.
Methylation of Cyclin D 2 Is Observed Frequently in Pancreatic Cancer but Is Also an Age-related Phenomenon in Gastrointestinal Tissues 1
TLDR
The promoter region of cyclin D2 undergoes age-related methylation in multiple tissues, but aberrant methylation is more often detected in tissues and juice samples of pancreatic cancer than in normal tissues.
Overexpression of Cdk6–cyclin D3 highly sensitizes cells to physical and chemical transformation
TLDR
2–5-fold overexpression of both Cdk6 and D3 enhances by 5×103–106-fold the susceptibility of the BALB/c3T3 and C3H10T1/2 mouse fibroblast lines to ultraviolet irradiation- as well as 3-methylcholanthrene-induced transformation, suggesting that deregulated expression of Cdk 6 and cyclinD3 may predispose cells to malignant transformation.
Intra-Tumoral Delivery of shRNA Targeting Cyclin D1 Attenuates Pancreatic Cancer Growth
TLDR
It is concluded that lentivirus-delivered shRNA targeting cyclin D1 suppresses the growth, invasiveness, tumorigenicity and pro-angiogenic potential of human pancreatic cancer cells, thereby raising the possibility that intratumoral injections of viruses targeting cycl in D1 could provide a new therapeutic approach in pancreatic ductal adenocarcinoma.
Dissociation of Gemcitabine Sensitivity and Protein Kinase B Signaling in Pancreatic Ductal Adenocarcinoma Models
TLDR
The results suggested that gemcitabine efficacy involving the PKB pathway depends on PKB activity, its mechanisms of enhanced activity, as well as its function in a signaling network.
PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
TLDR
This study unveils several RBM3‐regulated genes with potential clinical relevance in pancreatic cancer, among which PRR11 shows the most consistent association with disease severity, at both transcriptome and protein levels.
...
...